Contents

Search

geographic atrophy

Etiology: - macular degeneration - advanced dry form of age-related macular degeneration Epidemiology: - affects > 1 million people in the U.S. & 5 million people worldwide Complications: - major cause of adult blindness Management: - pegcetacoplan (Syfovre) injection administered every 25-60 days (FDA-approved) - maximum benefit between 18-24 months after initiating treatment. - avacincaptad pegol (Izeray)

General

retinal disease

References

  1. Marcus A FDA OKs First Drug for Geographic Atrophy, a Major Cause of Adult Blindness. Medscape. February 17, 2023 https://www.medscape.com/viewarticle/988460